Corrigendum to “Development of intranasal implantable devices for schizophrenia treatment” [Int. J. Pharm. 624 (2021) 122061] (International Journal of Pharmaceutics (2022) 624, (S0378517322006159), (10.1016/j.ijpharm.2022.122061))

1. Utomo, E.
2. Domínguez-Robles, J.
3. Moreno-Castellanos, N.
4. Stewart, S.A.
5. Picco, C.J.
6. Anjani, Q.K.
7. Simón, J.A.
8. Peñuelas, I.
9. Donnelly, R.F.
10. Larrañeta, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.IJPHARM.2022.122475 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus